Codeine
| Codeine | |
|---|---|
| Salts [] | |
|---|---|
| Codeine hydrobromide | |
| Codeine phosphate | |
| Codeine trisulfate | |
| Codeine diphosphate | |
| Codeine hemisulfate | |
| Codeine dihydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 299.40 g/mol [1] |
| Appearance | Orthorhombic crystals from water, dilute alcohol, ether [1] |
| Density | 1.32 at 68 °F (NTP, 1992) - Denser than water; will sink [1] |
| Melting point | 309 to 313 °F (after drying at 176 °F) (NTP, 1992) [1] |
| Boiling point | 482 °F at 22 mmHg (sublimes) (NTP, 1992) [1] |
| Decomposition | When heated to decomposition it emits toxic fumes of /nitrogen oxides/. [1] |
| Solubility | less than 1 mg/mL at 70 °F (NTP, 1992) [1] |
| Predicted LogP | 1.1 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C18H21NO3 |
| IUPAC name | (4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol |
| SMILES | CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O |
| InChI | InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3-6,11-13,17,20H,7-9H2,1-2H3/t11-,12+,13-,17-,18-/m0/s1 |
| InChIKey | OROGSEYTTFOCAN-DNJOTXNNSA-N |
| CAS number | 76-57-3 |
| UNII | UX6OWY2V7J |
| PubChem CID | 5284371 |
| Pharmacokinetics[] | |
|---|---|
| Onset | 15–30 minutes |
| Elimination half-life | 2.5–3 hours |
| Duration of action | 4–6 hours |
| Metabolism | Liver: CYP2D6 (to morphine), CYP3A4 (to norcodeine), UGT2B7 (to 3- and 6-glucuronides of codeine, norcodeine, and morphine)[3] |
| Routes of administration | By mouth, rectal, subcutaneous, intramuscular |
| Dependence liability | High |
| Addiction liability | High[4] |
| Toxicity [] | |
|---|---|
| LD50 | Rat: - oral: 427 mg/kg - ip: 100 mg/kg - sc: 229 mg/kg - iv: 75 mg/kg [1] |
Codeine (also known as Methylmorphine, Codicept, Codeine anhydrous, Coducept, l-Codeine, Morphine monomethyl ether, (-)-Codeine, O3-Methylmorphine, codeinum or Codeine base) is a antidepressant, depressant, hormone, opioid and prodrug substance of the morphinan class.
It is a constituent of opium.
Chemistry
Salts []
Stereochemistry []
Codeine is a single defined stereoisomer.
Druglikeness
Lipinski's rule of five
Codeine matches Lipinski's rule of five.Reagents
There are currently 10 reagent-interactions on DrugsPRO
| Reagent | Color change | Description |
|---|---|---|
| Marquis | dark purple | |
| Mecke | dark bluish green | |
| Mandelin | dark olive spots | |
| Liebermann | faint brown / black | |
| Froehde | faint yellow | |
| Robadope | no pink color change | |
| Simon's | no blue color change | |
| Ehrlich | no color change | |
| Hofmann | no color change | |
| Scott | no color change |
Pharmacology
ATC Classification
- respiratory system (R)
- cough and cold preparations (R05)
- cough suppressants, excl. combinations with expectorants (R05D)
- opium alkaloids and derivatives (R05DA)
- (R05DA04)
- codeine (R05DA04)
MeSH Classification
Mechanism of action []
Although the exact mechanism of action of codeine is still unknown, it is generally thought to be mediated through the agonism of opioid receptors, particularly the mu-opioid receptors. Morphine was previously postulated to contribute to the analgesic effect of codeine due to the O-demethylation of codeine to morphine by CYP2D6. Particularly, CYP2D6 poor metabolizer did not experience the analgesic effect of codeine. However, this is unlikely to be the main mechanism of action of codeine as only 5% of codeine is metabolized to morphine. Other hypotheses also postulate that codeine-6-glucuronide, the main metabolite of codeine, mediates the analgesic effect of codeine as it not only has an affinity to the mu receptors as codeine but also can be metabolized to morphine-6-glucuronide, which was observed to be more potent than morphine. Binding to the mu receptors by codeine activates the G-proteins Gα<sub>i</sub>, causing a decrease in intracellular cAMP and Ca<sup>2+</sup> level. This causes hyperpolarization of nociceptive neurons, thus imparing the transmission of pain signals. [1]
Metabolism
Codeine acts as a prodrug for:
| Metabolic pathways [] |
|---|
Interactions []
Medical side effects []
96 side effects listed on drug labels in SIDER 4.1 (codeine).
- Abdominal pain
- Gastrointestinal pain
- Angioedema
- Decreased appetite
- Anxiety
- Asthenia
- Fatigue
- Bone disorder
- Breast disorder
- Confusional state
- Feeling abnormal
- Malaise
- Constipation
- Dehydration
- Depression
- Diplopia
- Dizziness
- Syncope
- Lightheadedness
- Somnolence
- Dyspnoea
- Dermatitis
- Rash
- Eye disorder
- Body temperature increased
- Flushing
- Gastrointestinal disorder
- Hallucination
- Cardiac arrest
- Cardiac disorder
- Hypersensitivity
- Hypotension
- Orthostatic hypotension
- Body temperature decreased
- Hypothermia
- Immune system disorder
- Irritability
- Mediastinal disorder
- Miosis
- Muscle spasms
- Muscle rigidity
- Mydriasis
- Nausea
- Nervous system disorder
- Nervousness
- Tension
- Nightmare
- Palpitations
- Pancreatitis
- Piloerection
- Pruritus
- Convulsion
- Shock
- Sneezing
- Withdrawal syndrome
- Hyperhidrosis
- Sweating increased
- Loss of consciousness
- Tachycardia
- Tremor
- Shakiness
- Urethral disorder
- Urinary tract disorder
- Urticaria
- Vertigo
- Vomiting
- Dry mouth
- Yawning
- Urinary retention
- Agitation
- Excitement
- Mood swings
- Affect lability
- Drug withdrawal syndrome
- Intracranial pressure increased
- Respiratory arrest
- Discomfort
- Ill-defined disorder
- Dysphoria
- Respiratory depression
- Pulmonary function test decreased
- Euphoric mood
- Biliary colic
- Erythema
- Lacrimation increased
- Bradycardia
- Central nervous system stimulation
- Visual impairment
- Abdominal discomfort
- Insomnia
- Ureteral spasm
- Polyuria
- Nasopharyngitis
- Rhinorrhoea
- Cardiovascular insufficiency
- Loss of libido
Indications
- Cough
- Diarrhoea
- Dry cough
- Headache
- Pain
- Postoperative pain
Subjective effects []
| a1ko / Codeine [] | |
|---|---|
Routes:
| |
| emily / Codeine [] | |
|---|---|
Routes:
| |
| magnus / Codeine [] | |
|---|---|
Routes:
| |
| Mere / Codeine [] | |
|---|---|
| michalina / Codeine [] | |
|---|---|
Effects:
| |
| nervewing / Codeine [] | |
|---|---|
| Pilz / Codeine [] | |
|---|---|
Routes:
| |
| vivi / Codeine [] | |
|---|---|
Routes:
| |
Experience reports
Erowid
There are currently 30 experience reports involving codeine on Erowid: []- "Like My Closest Friend" by Andrew
- "World of Love" by Daniel Boone
- "Good Day Sunshine" by R
- "Opiate Reviews and Overviews" by Morphitron
- "Far Too Much Codeine" by Codeinated
- "Effects ruined by SSRI" by Cecilia
- "First Time Trial" by zophen
- "Drifting Mind's Eye Hallucinations" by Ginger
- "Kicking the Crutch" by Jack
- "An Incredible Buzz?" by Sour Lemon
- "Floating Inside a Marshmallow" by Mutiny
- "The Quintessential Substance" by Pointman
- "Hallucinosexual" by Jonas
- "Seeds of Addiction" by Noz
- "Sleep Apnea As An Effect" by HaSaam
- "Mellow, as Always" by Phlux
- "Dripping Bliss" by Wsup Den
- "Just Cannot Give It Up" by poppypossesed
- "Suicidal Recovery" by somatose
- "A Happy and Fluffy Afternoon" by Purple Grass
- "The Real Buzz" by GripNSip
- "Mindless Euphoria" by Mingus
- "Peace & Safety - Rectal Administration" by sackbut
- "My Dual Drug of Choice" by Stever
- "Frightened and Confused" by Niki
- "Good trip, Bad hangover" by Codeine/Cannabis
- "A Feeling of Calm" by Jow
- "Not as Tolerant as I Thought" by MongrelOctopus
- "The Long Struggle" by Aliasdck
- "What a Beautiful Drug It Is" by Anonymo the Wise
- "Every Drug I've taken so far (AMA)" by Used-Philosopher-408 (26 upvotes)
- "Weed + DPH + DXM + Codeine + Benzedrex + Hydroxyzine" by AdministrationMany53 (11 upvotes)
- "Bad trip?" by HourRepresentative48 (10 upvotes)
- "Description, comparison and rating of 14 opioids " by PsychedStrawberry (9 upvotes)
- "28mg of 25i-NBOMe Administered Nasally (x-post from /r/drugs)" by [deleted] (6 upvotes)
- "Found an incomplete trip report from my robo blackout. Read and AMA." by toopsychedforlife (6 upvotes)
- "First Opioid (Oxycodone) trip report" by -ZoXoXoZ- (5 upvotes)
- "October 2017, Bad Mushroom Trip." by skeletoneddie (5 upvotes)
- "The Holy Trinity (Diazepam, Alcohol and Codeine)" by NorthernWine (5 upvotes)
- "There are 45 psychedelic and dissociative trip reports in the Drug Users Bible: Download a free copy from here. Whether psychedelics are used for recreation, you need to look after yourself. Stay safe." by DMTrott (3 upvotes)
- "My robotripping experience" by Similar_Tradition893 (3 upvotes)
- "3 meo pcp and ptsd? Life changing" by wizardslashmagi (2 upvotes)
- "Floating above clouds" by nhsbytes (2 upvotes)
- "Deep Meditation and visuals, LSD 105 ug" by LxSxD (1 upvotes)
- "Out of body experience on Butane" by Ohtoboeh (0 upvotes)
- "Dispensary weed dispensed me of all mental capacity" by anon_Complex_380 (0 upvotes)
- "Dph trip report" by Frostyexe_ (0 upvotes)
Legal status []
- Australia: Codeine is a S8 / S4 (Prescription only).
- Brazil: Codeine is a A2 / Class C1.
- Canada: Codeine is a Schedule I.
- Germany: Codeine is a Anlage III under the "Betäubungsmittelgesetz (BtMG)".
- New Zealand: Codeine is a Class C2.[5]
- United Kingdom: Codeine is a Class B / Pharmacy medicine under the "Misuse of Drugs Act 1971".
- United States: Codeine is a Schedule II / Schedule III–V under the "Controlled Substances Act".
- United Nations: Codeine is a Schedule II and / and Narcotic and Schedule and III narcotic under the "Single Convention on Narcotic Drugs 1961".
- Other: Codeine is a SE: Förteckning III.[6]
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 5284371, Codeine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5284371
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Codeine. UNII: UX6OWY2V7J. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/UX6OWY2V7J
Shen H, He MM, Liu H, Wrighton SA, Wang L, Guo B, Li C. Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17. Drug Metabolism and Disposition. August 2007; 35(8):1292–1300. PMID 17470523. https://doi.org/10.1124/dmd.107.015354
Bonewit-West K, Hunt SA, Applegate E. Today's Medical Assistant: Clinical and Administrative Procedures. Elsevier Health Sciences. 2012. https://books.google.com/books?id=YalYPI1KqTQC&pg=PA571
Codeine Phosphate Datasheet. Medsafe. https://www.medsafe.govt.nz/profs/datasheet/c/codeinephosphatepsmtab.pdf
Citodon® (Tablett 500 mg/30 mg) • Produktresumé | FASS Vård. Fass.se. https://fass.se/health/product/19820312000059/smpc
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 03:36:06 |
| drugspro | ok | 2026-11-20 03:36:02 |
| erowid | ok | 2026-11-20 03:36:04 |
| gsrs | ok | 2026-11-20 03:36:07 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0004995) | 2026-11-20 03:36:02 |
| kegg | ok | 2026-11-20 03:36:04 |
| pubchem | ok | 2026-11-20 03:36:01 |
| ok | 2026-11-20 03:36:02 | |
| sider | ok | 2026-11-20 03:36:02 |
| structure | ok | 2026-11-20 03:36:02 |
| wikipedia | ok | 2026-11-20 03:36:02 |